90 related articles for article (PubMed ID: 15533297)
1. Efficacy of Trypan: a diminazene based drug as antileishmanial agent.
Macharia JC; Bourdichon AJ; Gicheru MM
Acta Trop; 2004; 92(3):267-72. PubMed ID: 15533297
[TBL] [Abstract][Full Text] [Related]
2. Activity, toxicity and analysis of resistance of essential oil from Chenopodium ambrosioides after intraperitoneal, oral and intralesional administration in BALB/c mice infected with Leishmania amazonensis: a preliminary study.
Monzote L; Montalvo AM; Scull R; Miranda M; Abreu J
Biomed Pharmacother; 2007; 61(2-3):148-53. PubMed ID: 17254746
[TBL] [Abstract][Full Text] [Related]
3. A trial of immunotherapy against Leishmania amazonensis infection in vitro and in vivo with Z-100, a polysaccharide obtained from Mycobacterium tuberculosis, alone or combined with meglumine antimoniate.
Barroso PA; Marco JD; Calvopina M; Kato H; Korenaga M; Hashiguchi Y
J Antimicrob Chemother; 2007 Jun; 59(6):1123-9. PubMed ID: 17439977
[TBL] [Abstract][Full Text] [Related]
4. Tamoxifen as a potential antileishmanial agent: efficacy in the treatment of Leishmania braziliensis and Leishmania chagasi infections.
Miguel DC; Zauli-Nascimento RC; Yokoyama-Yasunaka JK; Katz S; Barbiéri CL; Uliana SR
J Antimicrob Chemother; 2009 Feb; 63(2):365-8. PubMed ID: 19095684
[TBL] [Abstract][Full Text] [Related]
5. In-vitro and in-vivo studies on a topical formulation of sitamaquine dihydrochloride for cutaneous leishmaniasis.
Garnier T; Brown MB; Lawrence MJ; Croft SL
J Pharm Pharmacol; 2006 Aug; 58(8):1043-54. PubMed ID: 16872550
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory activity of limonene against Leishmania parasites in vitro and in vivo.
Arruda DC; Miguel DC; Yokoyama-Yasunaka JK; Katzin AM; Uliana SR
Biomed Pharmacother; 2009 Nov; 63(9):643-9. PubMed ID: 19321295
[TBL] [Abstract][Full Text] [Related]
7. Activity of physalins purified from Physalis angulata in in vitro and in vivo models of cutaneous leishmaniasis.
Guimarães ET; Lima MS; Santos LA; Ribeiro IM; Tomassini TB; Ribeiro dos Santos R; dos Santos WL; Soares MB
J Antimicrob Chemother; 2009 Jul; 64(1):84-7. PubMed ID: 19454526
[TBL] [Abstract][Full Text] [Related]
8. In vivo studies on the antileishmanial activity of buparvaquone and its prodrugs.
Garnier T; Mäntylä A; Järvinen T; Lawrence J; Brown M; Croft S
J Antimicrob Chemother; 2007 Oct; 60(4):802-10. PubMed ID: 17715126
[TBL] [Abstract][Full Text] [Related]
9. Successful topical treatment of murine cutaneous leishmaniasis with a combination of paromomycin (Aminosidine) and gentamicin.
Grogl M; Schuster BG; Ellis WY; Berman JD
J Parasitol; 1999 Apr; 85(2):354-9. PubMed ID: 10219319
[TBL] [Abstract][Full Text] [Related]
10. Effect of imidocarb and levamisole on the experimental infection of BALB/c mice by Leishmania (Leishmania) amazonensis.
Rodrigues FH; Afonso-Cardoso SR; Gomes MA; Beletti ME; Rocha A; Guimarães AH; Candeloro I; de Souza MA
Vet Parasitol; 2006 Jun; 139(1-3):37-46. PubMed ID: 16647821
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of the intralesional treatment with Chenopodium ambrosioides in the murine infection by Leishmania amazonensis.
Patrício FJ; Costa GC; Pereira PV; Aragão-Filho WC; Sousa SM; Frazão JB; Pereira WS; Maciel MC; Silva LA; Amaral FM; Rebêlo JM; Guerra RN; Ribeiro MN; Nascimento FR
J Ethnopharmacol; 2008 Jan; 115(2):313-9. PubMed ID: 18035510
[TBL] [Abstract][Full Text] [Related]
12. Leishmania major: in vitro and in vivo anti-leishmanial effect of cantharidin.
Ghaffarifar F
Exp Parasitol; 2010 Oct; 126(2):126-9. PubMed ID: 20435039
[TBL] [Abstract][Full Text] [Related]
13. Prophylactic treatment of BALB/c mice with cyclosporine A and its analog B-5-49 enhances resistance to Leishmania major.
Behforouz NC; Wenger CD; Mathison BA
J Immunol; 1986 Apr; 136(8):3067-75. PubMed ID: 3958489
[TBL] [Abstract][Full Text] [Related]
14. Leishmanicidal activity of Himatanthus sucuuba latex against Leishmania amazonensis.
Soares DC; Andrade AL; Delorenzi JC; Silva JR; Freire-de-Lima L; Falcão CA; Pinto AC; Rossi-Bergmann B; Saraiva EM
Parasitol Int; 2010 Jun; 59(2):173-7. PubMed ID: 20096374
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of chalcone analogues with increased antileishmanial activity.
Boeck P; Bandeira Falcão CA; Leal PC; Yunes RA; Filho VC; Torres-Santos EC; Rossi-Bergmann B
Bioorg Med Chem; 2006 Mar; 14(5):1538-45. PubMed ID: 16386424
[TBL] [Abstract][Full Text] [Related]
16. In vivo activity of perifosine against Leishmania amazonensis.
Cabrera-Serra MG; Valladares B; Piñero JE
Acta Trop; 2008 Oct; 108(1):20-5. PubMed ID: 18801328
[TBL] [Abstract][Full Text] [Related]
17. Immunomodulatory effect of Canova medication on experimental Leishmania amazonensis infection.
Pereira WK; Lonardoni MV; Grespan R; Caparroz-Assef SM; Cuman RK; Bersani-Amado CA
J Infect; 2005 Aug; 51(2):157-64. PubMed ID: 16038768
[TBL] [Abstract][Full Text] [Related]
18. Selection and phenotype characterisation of sitamaquine-resistant promastigotes of Leishmania donovani.
Bories C; Cojean S; Huteau F; Loiseau PM
Biomed Pharmacother; 2008 Mar; 62(3):164-7. PubMed ID: 18249083
[TBL] [Abstract][Full Text] [Related]
19. Colloidal, in vitro and in vivo anti-leishmanial properties of transfersomes containing paromomycin sulfate in susceptible BALB/c mice.
Bavarsad N; Fazly Bazzaz BS; Khamesipour A; Jaafari MR
Acta Trop; 2012 Oct; 124(1):33-41. PubMed ID: 22750480
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, in vitro evaluation, and antileishmanial activity of water-soluble prodrugs of buparvaquone.
Mäntylä A; Garnier T; Rautio J; Nevalainen T; Vepsälainen J; Koskinen A; Croft SL; Järvinen T
J Med Chem; 2004 Jan; 47(1):188-95. PubMed ID: 14695832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
